ICON plc

ICLRintermediary

ICON is the world's second-largest CRO (contract research organization), managing clinical trials for pharma and biotech companies globally. CROs like ICON benefit from biopharma R&D outsourcing trends.

⇄ Compare

Productos e Ingresos

Participación de Ingresos por Producto

Desglose de Ingresos ($8.3B)

Datos estáticos (cargando finanzas en tiempo real…)

Clinical Research Services (100%)

Composición de segmentos y clientes principales

Detalles del producto

Clinical Development Services75%

Phase I-IV clinical trials, data management, biostatistics — full-service CRO.

PRA Health Sciences (Legacy)25%

Acquired PRA 2021 — integrated services doubling ICON's scale.

Relaciones en la Cadena de Suministro

Clientes Clave

Pfizer Inc.

Clinical trial services

Impacto: large

Eli Lilly and Company

Clinical trial services

Impacto: growing

Contexto macro y de mercado

헬스케어Noticias del sector

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Próximos catalizadores

◆CMS 메디케어 최종 수가 발표 (2026.Q2)◆UNH/HUM/CVS Q1 실적 (2026.04)◆IRA 약가 협상 2차 품목 공개

Últimas noticias

Cargando noticias...

Análisis IA

Haz clic en "Obtener Análisis IA" para un análisis de cadena de suministro de ICON plc impulsado por IA.

Información de la Empresa

Sede Central

Dublin, Ireland

Fundación

1990

Empleados

40,000

Sitio Web

iconplc.com

Estado del sector — 헬스케어

Noticias del sector